Watch Demo

Germany Antidiabetics Industry Outlook 2024 - 2028

See how Germany Antidiabetics performed compared to key markets such as France and Italy.

Key Market Indicators

Germany's insulin export market is projected to see modest growth, reaching an estimated $3.7 billion by 2028, up from $3.6 billion in 2023. This marks an average annual growth rate of 0.3%. The country's insulin supply has been on an upward trajectory, increasing by 2.2% annually since 1996. In the global ranking, Germany's insulin export market is closely followed by France, Italy, and China, occupying the second, third, and fourth spots, respectively. On the import front, Germany's insulin market is anticipated to hit approximately $692 million by 2028, rising from $674 million in 2023. This also represents a 0.3% annual growth rate. German demand for insulin has experienced a slower but steady increase, growing at an average rate of 0.6% per year since 1996.

Marketing Banner

Germany Antidiabetics Market Data and Forecasts

How much will Germany Antidiabetics Market grow to 2028?

Forecast: Export of Insulin in Dosage Forms from Germany
Forecast: Insulin in Dosage Market Size Value in Germany
Forecast: Import of Insulin in Dosage Forms to Germany
Forecast: Import of Insulin to Germany
More in Antidiabetics Industry for 2028